1
746
Synthesis
T. B. Nguyen et al.
Paper
2-(3-Fluorophenyl)-1H-benzimidazole (3ag)
2-(Furan-2-yl)-1H-benzimidazole (3al)
Prepared according to the general procedure using 1a (345 mg, 2.5
mmol), and 3-fluorobenzyl alcohol (2g, 378 mg, 3 mmol). Purification
according to the general procedure afforded a pale yellow solid; yield:
Prepared according to the general procedure using 1a (345 mg, 2.5
mmol), and furan-2-ylmethanol (2l, 294 mg, 3 mmol). Purification
according to the general procedure afforded a grey solid; yield: 202
17
14
424 mg (80%); mp 255–256 °C (Lit. 258 °C).
mg (44%); mp 285–286 °C (Lit. 287 °C).
1
1
H NMR (300 MHz, CD OD): δ = 7.90–7.79 (m, 2 H), 7.62–7.49 (m, 3
H NMR (300 MHz, DMSO-d ): δ = 12.94 (s, 1 H), 7.94 (dd, J = 1.8, 0.7
3
6
H), 7.28–7.18 (m, 3 H).
Hz, 1 H), 7.66–7.49 (m, 2 H), 7.23–7.17 (m, 3 H), 6.73 (dd, J = 3.5, 1.8
1
3
Hz, 1 H).
C NMR (75 MHz, CD OD): δ = 164.7 (d, J = 245 Hz), 152.1 (d, J = 26
3
13
Hz), 133.4 (d, J = 7.0 Hz), 132.2 (d, J = 8.6 Hz), 124.4, 123.7 (d, J = 3.0
Hz), 118.1 (d, J = 21.5 Hz), 114.7 (d, J =23.4 Hz) (1 C missing due to
overlap).
C NMR (75 MHz, DMSO-d ): δ = 145.6, 144.6, 143.6, 134.2, 122.6,
6
121.9, 118.8, 112.3, 111.3, 110.5 (1 C missing due to overlap).
2-(Thiophen-2-yl)-1H-benzimidazole (3am)
2
-(4-Chlorophenyl)-1H-benzimidazole (3ah)
Prepared according to the general procedure using 1a (345 mg, 2.5
mmol), and thiophen-2-ylmethanol (2m, 342 mg, 3 mmol). Purifica-
tion by column chromatography (alumina, heptane–EtOAc, 2:1) af-
forded a pale yellow solid; yield: 421 mg (84%); mp 300–301 °C (Lit.16
285–287 °C).
Prepared according to the general procedure using 1a (345 mg, 2.5
mmol), and 4-chlorobenzyl alcohol (2h, 428 mg, 3 mmol). Purifica-
tion according to the general procedure afforded a pale yellow solid;
13
yield: 515 mg (90%); mp 305 °C (Lit. 289−291 °C).
1
1
H NMR (300 MHz, DMSO-d ): δ = 13.02 (br s, 1 H), 8.20 (d, J = 8.7 Hz,
H NMR (500 MHz, DMSO-d ): δ = 12.93 (s, 1 H), 7.84 (d, J = 3.5 Hz, 1
6
6
2
H), 7.63–7.59 (m, 4 H), 7.23–7.19 (m, 2 H).
H), 7.72 (d, J = 5.0 Hz, 1 H), 7.61–7.51 (m, 2 H), 7.23 (dd, J = 5.0, 3.5 Hz,
1
3
1 H), 7.20–7.18 (m, 2 H).
C NMR (75 MHz, DMSO-d ): δ = 150.1, 134.4, 129.0, 128.1, 122.2,
6
13
1
15.1.
C NMR (125 MHz, DMSO-d ): δ = 146.9, 143.6, 134.7, 133.6, 128.7,
6
128.2, 126.7, 122.4, 122.0, 118.5, 111.0.
2-(4-Bromophenyl)-1H-benzimidazole (3ai)
2
-(Pyridin-3-yl)-1H-benzimidazole (3an)
Prepared according to the general procedure using 1a (345 mg, 2.5
mmol), and 4-bromobenzyl alcohol (2i, 645 mg, 3 mmol). Purification
according to the general procedure afforded a pale yellow solid; yield:
Prepared according to the general procedure using 1a (345 mg, 2.5
mmol), and pyridin-3-ylmethanol (2n, 327 mg, 3 mmol). Purification
according to the general procedure afforded a grey solid; yield: 293
18
570 mg (84%); mp 300 °C (Lit. 299 °C).
14
1
mg (60%); mp 250 °C (Lit. 247 °C).
H NMR (300 MHz, DMSO-d ): δ = 13.01 (s, 1 H), 8.13 (d, J = 8.5 Hz, 2
6
1
H), 7.76 (d, J = 8.5 Hz, 2 H), 7.62–7.59 (m, 2 H), 7.25–7.19 (m, 2 H).
H NMR (300 MHz, CD OD): δ = 9.23–9.21 (m, 1 H), 8.62–8.60 (m, 1
3
1
3
H), 8.44–8.42, (m, 1 H), 7.61–7.53 (m, 3 H), 7.27–7.24 (m, 2 H).
C NMR (75 MHz, DMSO-d ): δ = 150.2, 131.9, 129.4, 128.4, 123.2,
6
13
1
22.3, 115.4.
C NMR (75 MHz, CD OD): δ = 151.4, 150.3, 148.5, 140.6, 136.0,
3
128.0, 125.7, 124.5, 116.3.
2-(2-Iodophenyl)-1H-benzimidazole (3aj)
5
-Methyl-2-phenyl-1H-benzimidazole (3ba)
Prepared according to the general procedure using 1a (345 mg, 2.5
mmol), and 2-iodobenzyl alcohol (2j, 702 mg, 3 mmol). Purification
according to the general procedure and an additional recrystallization
Prepared according to the general procedure using 1b (380 mg, 2.5
mmol), and benzyl alcohol (2a, 324 mg, 3 mmol). Purification accord-
ing to the general procedure afforded a pale yellow solid; yield: 451
(
MeOH) afforded a pale yellow solid; yield: 650 mg (81%); mp 255–
17
20
256 °C (Lit. 258 °C).
mg (87%); mp 244–245 °C (Lit. 244–246 °C).
1
1
H NMR (300 MHz, DMSO-d ): δ = 12.74 (br s, 1 H), 8.06 (d, J = 7.9 Hz,
H NMR (300 MHz, CD OD): δ = 8.07 (m, 2 H), 7.52 (m, 4 H), 7.40 (s, 1
6
3
1
H), 7.71–7.52 (m, 3 H), 7.30–7.23 (m, 4 H).
H), 7.10 (d, J = 7.8 Hz, 1 H), 2.48 (s, 3 H).
13
13
C NMR (75 MHz, DMSO-d ): δ = 152.6, 143.1, 139.6, 136.6, 134.4,
C NMR (75 MHz, CD OD): δ = 151.6, 132.5, 129.9, 129.1, 128.8,
6
3
131.3, 131.2, 128.1, 122.4, 121.7, 119.1, 111.5, 97.4.
126.3, 124.1, 117.3, 111.1, 20.4 (2 C missing due to overlap).
2-[4-(Trifluoromethyl)phenyl]-1H-benzimidazole (3ak)
7-Methyl-2-phenyl-1H-benzimidazole (3ca)
Prepared according to the general procedure using 1a (345 mg, 2.5
mmol), and 4-(trifluoromethyl)benzyl alcohol (2k, 528 mg, 3 mmol).
Purification according to the general procedure afforded a white sol-
Prepared according to the general procedure using 1c (380 mg, 2.5
mmol), and benzyl alcohol (2a, 324 mg, 3 mmol). Purification accord-
ing to the general procedure afforded a pale yellow solid; yield: 358
19
21
id; yield: 501 mg (76%); mp 263–265 °C (Lit. 265–266 °C).
mg (69%); mp 244–246 °C (Lit. 246–248 °C).
1
1
H NMR (300 MHz, CD OD): δ = 8.23 (d, J = 7.8 Hz, 2 H), 7.82 (d, J = 7.8
H NMR (300 MHz, CD OD): δ = 8.14 (d, J = 7.8, 1.8 Hz, 2 H), 7.55 (m, 3
3
3
Hz, 2 H), 7.70–7.54 (m, 2 H), 7.31–7.26 (m, 2 H).
H), 7.45 (s, 1 H), 7.16 (t, J = 7.6 Hz, 1 H), 7.06 (d, J = 7.6 Hz, 1 H), 2.64 (s,
1
3
3 H).
C NMR (75 MHz, CD OD): δ = 150.2, 143.5, 134.9, 133.3, 131.3 (q, J =
3
13
3
2 Hz), 126.9, 125.7 (q, J = 3.8 Hz), 124.0 (q, J = 270 Hz), 118.1, 111.5.
C NMR (75 MHz, CD OD): δ = 153.1, 131.3, 131.2, 130.3, 130.0,
3
128.2, 128.1, 128.0, 124.5, 123.9, 113.7, 17.1.
©
Georg Thieme Verlag Stuttgart · New York — Synthesis 2015, 47, 1741–1748